Characterisation of the conformational changes of GlnH that stimulate PknG activity in Mycobacteria and Corynebacterium glutamicum

GlnH is an amino acid binding protein that senses aspartate to regulate metabolism via the PknG pathway in diverse Actinobacteria. Information about ligand occupancy of periplasmic GlnH is conveyed to PknG via an uncharacterised transmembrane protein GlnX. This pathway is important in the virulence of Mycobacterium tuberculosis, and in regulating valuable industrial fermentations by Corynebacterium glutamicum. GlnH has a "Venus flytrap"-like structure, comprising two lobes that surround the ligand aspartate. However, the conformational changes that allow GlnH to initiate this signalling pathway are unknown. To address this question, we produced GlnH from pathogens M. tuberculosis and Mycobacterium marinum and non-pathogens Mycobacterium smegmatis and C. glutamicum and used X-ray crystallography and cryo-EM to determine their structures. The results show that amino acid specificity is conserved in all homologues. However, GlnH from Mycobacteria was monomeric and bound aspartate with nanomolar affinity, whereas GlnH from C. glutamicum bound aspartate with micromolar affinity and dimerised upon binding. Whilst GlnH of the non-pathogens was stable at neutral pH, GlnH from the pathogens was most stable at acidic pH, reflecting the environment of host phagosomes. Structures were determined for all homologues, but only M. smegmatis GlnH crystallised in both unbound (Apo) and Asp-bound forms. GlnH has an open structure with a cleft between the lobes to permit access to aspartate. The Asp-bound structure is more compact with the lobes locked together, completely enclosing the ligand. AlphaFold was used to design mutations to disrupt the predicted GlnH-GlnX interface, and these variants failed to complement the metabolic defect of glnX knockout in M. smegmatis, supporting the predicted complex and suggesting how the GlnH conformational change is transmitted GlnX to initiate signalling.